EagleClaw Capital Management’s Cigna CI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.53M | Sell |
5,565
-2,864
| -34% | -$809K | 0.21% | 77 |
|
|
2026
Q1 | $2.25M | Sell |
8,429
-5,772
| -41% | -$1.6M | 0.31% | 72 |
|
|
2025
Q4 | $3.91M | Hold |
14,201
| – | – | 0.57% | 47 |
|
|
2025
Q3 | $4.09M | Buy |
14,201
+1,170
| +9% | +$346K | 0.57% | 46 |
|
|
2025
Q2 | $4.31M | Sell |
13,031
-125
| -1% | -$40.3K | 0.64% | 44 |
|
|
2025
Q1 | $4.33M | Buy |
13,156
+777
| +6% | +$234K | 0.68% | 47 |
|
|
2024
Q4 | $3.42M | Sell |
12,379
-5
| -0% | -$1.59K | 0.54% | 50 |
|
|
2024
Q3 | $4.29M | Buy |
12,384
+285
| +2% | +$98.1K | 0.72% | 44 |
|
|
2024
Q2 | $4M | Sell |
12,099
-25
| -0.2% | -$8.62K | 0.72% | 42 |
|
|
2024
Q1 | $4.4M | Sell |
12,124
-190
| -2% | -$62.5K | 0.8% | 42 |
|
|
2023
Q4 | $3.69M | Sell |
12,314
-5
| -0% | -$1.46K | 0.77% | 45 |
|
|
2023
Q3 | $3.52M | Buy |
12,319
+146
| +1% | +$41.6K | 0.8% | 43 |
|
|
2023
Q2 | $3.42M | Hold |
12,173
| – | – | 0.79% | 48 |
|
|
2023
Q1 | $3.11M | Sell |
12,173
-50
| -0.4% | -$14.6K | 0.73% | 49 |
|
|
2022
Q4 | $4.05M | Sell |
12,223
-25
| -0.2% | -$7.91K | 0.98% | 38 |
|
|
2022
Q3 | $3.4M | Sell |
12,248
-44
| -0.4% | -$12.4K | 0.95% | 37 |
|
|
2022
Q2 | $3.24M | Sell |
12,292
-50
| -0.4% | -$12.9K | 0.88% | 38 |
|
|
2022
Q1 | $2.96M | Sell |
12,342
-224
| -2% | -$52.4K | 0.68% | 50 |
|
|
2021
Q4 | $2.89M | Sell |
12,566
-317
| -2% | -$67.4K | 0.63% | 46 |
|
|
2021
Q3 | $2.58M | Buy |
12,883
+510
| +4% | +$111K | 0.66% | 50 |
|
|
2021
Q2 | $2.93M | Buy |
12,373
+48
| +0.4% | +$12K | 0.76% | 41 |
|
|
2021
Q1 | $2.98M | Buy |
12,325
+780
| +7% | +$174K | 0.86% | 36 |
|
|
2020
Q4 | $2.4M | Sell |
11,545
-632
| -5% | -$124K | 0.76% | 41 |
|
|
2020
Q3 | $2.06M | Sell |
12,177
-100
| -0.8% | -$17.6K | 0.72% | 43 |
|
|
2020
Q2 | $2.31M | Sell |
12,277
-310
| -2% | -$58.8K | 0.9% | 37 |
|
|
2020
Q1 | $2.23M | Hold |
12,587
| – | – | 1.06% | 33 |
|
|
2019
Q4 | $2.57M | Buy |
12,587
+452
| +4% | +$82.9K | 0.94% | 36 |
|
|
2019
Q3 | $1.84M | Buy |
12,135
+1,449
| +14% | +$236K | 0.75% | 45 |
|
|
2019
Q2 | $1.69M | Buy |
10,686
+1,944
| +22% | +$305K | 0.73% | 44 |
|
|
2019
Q1 | $1.41M | Buy |
8,742
+41
| +0.5% | +$7.49K | 0.64% | 52 |
|
|
2018
Q4 | $1.65M | Buy |
+8,701
| New | +$1.82M | 0.87% | 40 |
|
Other funds holding CI
EagleClaw Capital Management's CI Position: Q2 2026 in Review
EagleClaw Capital Management reduced its Cigna (CI) stake by 34% in Q2 2026, selling an estimated $809K and leaving 5,565 shares worth $1.53M. The position accounts for 0.21% of the portfolio, ranked #77.
EagleClaw Capital Management first reported a position in CI in Q4 2018 and has held it in 31 quarters since. The position peaked at $4.4M in Q1 2024. 1,702 funds tracked by Wall St. Rank hold CI as of Q2 2026.
- EagleClaw Capital Management held 5,565 shares of Cigna worth $1.53M as of Q2 2026.
- EagleClaw Capital Management sold 2,864 Cigna shares in Q2 2026, an estimated $809K.
- Cigna made up 0.21% of EagleClaw Capital Management's portfolio in Q2 2026, its #77 holding.
- EagleClaw Capital Management first reported a position in Cigna in Q4 2018 and has held it in 31 quarters since.
- EagleClaw Capital Management's Cigna position peaked at $4.4M in Q1 2024.
- 1,702 funds tracked by Wall St. Rank held Cigna as of Q2 2026.
Based on EagleClaw Capital Management's 13F filing for Q2 2026, filed 10 Aug 2026.